12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | March 21, 2023 01:31pm

Gainers

• Quince Therapeutics (NASDAQ:QNCX) shares increased by 67.5% to $1.41 during Tuesday's regular session. As of 13:30 EST, this security is trading at a volume of 46.3 million shares, making up 3355.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.1 million.
• Pear Therapeutics (NASDAQ:PEAR) shares increased by 60.87% to $0.34. Trading volume for this security as of 13:30 EST is 17.7 million, which is 7582.1% of its average full-day volume over the last 100 days. The company's market cap stands at $47.2 million.
• Dermata Therapeutics (NASDAQ:DRMA) shares increased by 49.68% to $2.38. Dermata Therapeutics's stock is trading at a volume of 4.2 million shares as of 13:30 EST. This is 363.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.8 million.
• Homology Medicines (NASDAQ:FIXX) stock rose 33.1% to $1.21. Homology Medicines's stock is trading at a volume of 228.6K shares as of 13:30 EST. This is 171.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $69.8 million.
• ImmunityBio (NASDAQ:IBRX) shares rose 32.22% to $1.78. ImmunityBio's stock is trading at a volume of 6.0 million shares as of 13:30 EST. This is 216.5% of its average full-day volume over the last 100 days. The company's market cap stands at $777.9 million.
• Novo Integrated Sciences (NASDAQ:NVOS) stock rose 31.75% to $0.13. Novo Integrated Sciences's stock is trading at a volume of 50.6 million shares as of 13:30 EST. This is 192.4% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million.

Losers

• Altimmune (NASDAQ:ALT) shares decreased by 53.2% to $5.12 during Tuesday's regular session. Trading volume for Altimmune's stock is 16.2 million as of 13:30 EST. This is 1338.0% of its average full-day volume over the last 100 days. The company's market cap stands at $252.0 million.
• Gelesis Holdings (NYSE:GLS) stock fell 27.68% to $0.15. Trading volume for Gelesis Holdings's stock is 748.8K as of 13:30 EST. This is 238.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.1 million.
• Allarity Therapeutics (NASDAQ:ALLR) stock decreased by 23.01% to $0.11. As of 13:30 EST, Allarity Therapeutics's stock is trading at a volume of 8.1 million, which is 237.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 million.
• Ainos (NASDAQ:AIMD) stock decreased by 16.94% to $1.03. The current volume of 204.8K shares is 20.6% of Ainos's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $20.6 million.
• Viking Therapeutics (NASDAQ:VKTX) stock declined by 16.23% to $9.74. As of 13:30 EST, Viking Therapeutics's stock is trading at a volume of 3.7 million, which is 189.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $764.0 million.
• Aziyo Biologics (NASDAQ:AZYO) stock decreased by 15.87% to $1.22. Trading volume for Aziyo Biologics's stock is 879.7K as of 13:30 EST. This is 1294.7% of its average full-day volume over the last 100 days. The company's market cap stands at $19.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIMD ALLR ALT AZYO DRMA FIXX GLS IBRX NVOS PEAR QNCX VKTX